25
Participants
Start Date
March 31, 1998
Primary Completion Date
February 29, 2004
Study Completion Date
February 29, 2004
filgrastim
carboplatin
docetaxel
gemcitabine hydrochloride
University of Pittsburgh Cancer Institute, Pittsburgh
National Cancer Institute (NCI)
NIH
University of Pittsburgh
OTHER